Drug Profile
Research programme: antibody-drug conjugates - Ambrx/Eloxx Pharmaceuticals
Latest Information Update: 13 Mar 2024
Price :
$50
*
At a glance
- Originator Ambrx; Fabrus
- Class Antibodies; Drug conjugates
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Unspecified